Patients with acute CF have increased osteoclast formation and bone resorption compared with diabetic participants (DP) and healthy participants (HP), as a result of the RANKL pathway.31 Osteoclasts generated in CF were found to have greater activity after the addition of sRANKL, compared with the DP and HP. This evidence concerns the gene TNFSF11 and cystic fibrosis.